Excelsior Sciences Funding Round

12/4/2025

Debt
Venture Equity

$95,000,000

Series A

The company intends to use the funds to invest in its internal pipeline and build partnerships across a range of industry sectors, including therapeutics and materials science.

Private & Independent

Biopharmaceutical

Undisclosed
New York, NY Undisclosed
USA

Undisclosed

Not Recorded

Excelsior Sciences is leveraging a new form of chemistry that machines can do, AI can learn from, and anyone can engage. With our smart blocc platform, we're ending chemistry's 200-year artisanal phase and ushering in its automated era, reducing cost and complexity while making molecular solutions accessible across industries. We are developing our own proprietary therapeutic pipeline while also collaborating with partners across industries where small molecules are key -- including pharmaceuticals, materials science, and agtech. By combining proprietary chemistry with a closed-loop discovery and manufacturing platform, we enable the creation of superior small-molecule solutions and unlock new possibilities for innovation across these sectors.